← Leaderboards
John A Tayek
La Biomed Res Inst/ Harbor Ucla Med Ctr
$2,206,928
Attributed
$2,206,928
Total exposure
9
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $196.8K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$2,206,928 · 9
By mechanism
M01$1,672,720 · 8
R21$534,208 · 1
Top collaborators
No co-investigators on record.
Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr
Same institution · by research overlap
- Joel David Kopple$6,785,780
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchGlucose MetabolismGluconeogenesisHuman Therapy EvaluationNoninsulin Dependent Diabetes MellitusLeucineProtein MetabolismCortisolNutrition Related TagInsulinInsulin Sensitivity /ResistanceMalnutritionAminoacid MetabolismHead /Neck NeoplasmOutcomes ResearchHypoglycemic AgentsDrug Screening /EvaluationGlucagonInjection /InfusionCancer ComplicationCachexiaBlood ToxicologyDiabetes Mellitus
Grant awards (24)
Arginine Treatment for Alcoholic Hepatitis$169,373
R21 · FY2007 · AT · contact PI
Arginine Treatment for Alcoholic Hepatitis$167,995
R21 · FY2006 · AT · contact PI
Arginine Treatment for Alcoholic Hepatitis$196,840
R21 · FY2005 · AT
RU 486 AND GLUCOSE METABOLISM$237,978
M01 · FY2001 · RR
METABOLIC PROCESSES BEHIND CANCER CACHEXIA$237,978
M01 · FY2001 · RR
HORMONAL CONTROL OF GLUCONEOGENESIS IN DIABETES MELLITUS$237,978
M01 · FY2001 · RR
INFECTION IN HUMANS--VITAMIN A AND SEPSIS$237,978
M01 · FY2001 · RR
DIRECT EFFECTS OF PIOGLITAZONE ON GLUCONEOGENESIS IN TYPE II DIABETES$237,978
M01 · FY2001 · RR
ABNORMAL GLUCONEOGENESIS IN TYPE II DIABETES$237,978
M01 · FY2001 · RR
ENTERAL NUTRITION IN SEPSIS AND INJURY$237,978
M01 · FY2001 · RR
METABOLIC PROCESSES BEHIND CANCER CACHEXIA$982
M01 · FY2000 · RR
HORMONAL CONTROL OF GLUCONEOGENESIS IN DIABETES MELLITUS$982
M01 · FY2000 · RR
INFECTION IN HUMANS--VITAMIN A AND SEPSIS$982
M01 · FY2000 · RR
RU 486 AND GLUCOSE METABOLISM$982
M01 · FY2000 · RR
ENTERAL NUTRITION IN SEPSIS AND INJURY$982
M01 · FY2000 · RR
ABNORMAL GLUCONEOGENESIS IN TYPE II DIABETES$982
M01 · FY2000 · RR
DIRECT EFFECTS OF PIOGLITAZONE ON GLUCONEOGENESIS IN TYPE II DIABETES$982
M01 · FY2000 · RR
Effect of ethnicity on lipid, glucose &protein metabolism before &after troglit$0
M01 · FY2000 · RR
Effect of ethnicity on lipid, glucose &protein metabolism before &after troglit$0
M01 · FY2000 · RR
Effect of ethnicity on lipid, glucose &protein metabolism before &after troglit$0
M01 · FY2000 · RR
DIRECT EFFECTS OF PIOGLITAZONE ON GLUCONEOGENESIS IN TYPE II DIABETES$0
M01 · FY2000 · RR
DIRECT EFFECTS OF PIOGLITAZONE ON GLUCONEOGENESIS IN TYPE II DIABETES$0
M01 · FY2000 · RR
METABOLIC PROCESSES BEHIND CANCER CACHEXIA$0
M01 · FY2000 · RR
METABOLIC PROCESSES BEHIND CANCER CACHEXIA$0
M01 · FY2000 · RR